She had been diagnosed with lung adenocarcinoma with bone metastases; molecular analyses revealed that the tumor was negative for EGFR mutations and ALK gene rearrangements and that <1% of the tumor cells expressed PD‐L1. This evidence concerns the gene ALK and neoplasm.